Search Within

David H Ilson

  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (16)
Groups
  1. Department of Medicine (33)
  2. Gastrointestinal Oncology Service (33)
  3. Genitourinary Oncology Service (33)
  4. Solid Tumor Oncology Division (33)
  5. GSK Faculty (26)
  6. Hematologic Malignancies, Division of (26)

More Groups

People
  1. Yelena Janjigian (28)
  2. David Solit (26)
  3. Geoffrey Ku (26)
  4. Nikolaus Schultz (21)
  5. Jaclyn Hechtman (19)
  6. David Kelsen (18)

More People

Years
  1. 2023 (3)
  2. 2022 (2)
  3. 2021 (3)
  4. 2020 (3)
  5. 2019 (7)
  6. 2018 (3)

More Years

Publications
  1. Journal of Clinical Oncology (14)
  2. Clinical Cancer Research (3)
  3. Annals of Oncology (2)
  4. Cancer Discovery (2)
  5. Lancet Oncology (2)
  6. Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (14)
  2. American Association for Cancer Research (6)
  3. Oxford University Press (4)
  4. Elsevier Inc. (3)
  5. Elsevier Science, Inc. (2)
  6. Springer (2)

More Publishers

Results (33)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic predictors of response to systemic therapy in esophagogastric cancer
    Journal Article

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Chatila, W. K.; Hechtman, J. F.; Ku, G. Y.; Riches, J. C.; Tuvy, Y.; Kundra, R.; Bouvier, N.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Correlation of benefit from immune checkpoint inhibitors with next gen sequencing (NGS) profiles in esophagogastric cancer (EGC) patients
    Meeting Abstract

    Ku, G. Y.; Sanchez-Vega, F.; Chatila, W.; Margolis, M.; Fein, C.; Ilson, D. H.; Hechtman, J. F.; Tuvy, Y.; Bouvier, N.; Kundra, R.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Emergence of RTK/RAS/PI3K pathway alterations in trastuzumab-refractory HER2-positive esophagogastric (EG) tumors
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Tuvy, Y.; Bouvier, N.; Riches, J. C.; Margolis, M.; Millang, B. M.; Scott, S. N.; Kundra, R.; Castel, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Tuvy, Y.; Bouvier, N.; Riches, J.; Kundra, R.; Ku, G.; Hechtman, J. F.; Kelsen, D.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Genomic profiling of esophagogastric (EG) tumors in clinical practice
    Meeting Abstract

    Riches, J. C.; Schultz, N.; Ku, G. Y.; Imtiaz, T.; Kelsen, D. P.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; Ladanyi, M.; Arcila, M. E.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase II study of afatinib (A) in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab (T) refractory esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Imtiaz, T.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; Vakiani, E.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab-refractory esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Capanu, M.; Imtiaz, T.; Kelsen, D. P.; Ku, G. Y.; Schattner, M.; Brown, K. T.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab-refractory esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Capanu, M.; Gromisch, C. M.; Kelsen, D. P.; Ku, G. Y.; Brown, K. T.; Schattner, M.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Clinical relevance of the I(12p) marker chromosome in germ cell tumors
    Journal Article

    Bosl, G. J.; Ilson, D. H.; Rodriguez, E.; Motzer, R. J.; Reuter, V. E.; Chaganti, R. S. K.
    JNCI: Journal of the National Cancer Institute (1994)

    Fulltext@MSK | Save
  • Phase II trial of topotecan in patients with advanced renal cell carcinoma
    Journal Article

    Murray Law, T.; Ilson, D. H.; Motzer, R. J.
    Investigational New Drugs (1994)

    Fulltext@MSK | Save